Cargando…
Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
BACKGROUND: Current treatment of acute leukemia is based on anthracycline chemotherapy. Anthracyclines, despite improving patient survival, have serious cardiotoxicity and therefore cardiac monitoring should be a priority. The purpose of this study is to explore the possible early predictors of anth...
Autores principales: | Zhou, Xi, Weng, Yue, Jiang, Tiantian, Ou, Wenxin, Zhang, Nan, Dong, Qian, Tang, Xiaoqiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571315/ https://www.ncbi.nlm.nih.gov/pubmed/37833648 http://dx.doi.org/10.1186/s12885-023-11060-5 |
Ejemplares similares
-
Study on influencing factors of anthracycline-induced subclinical cardiotoxicity in DLBCL patients administered (R)-CHOP
por: Dong, Qian, et al.
Publicado: (2022) -
Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
por: Hu, Hui-Min, et al.
Publicado: (2018) -
Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020) -
Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017) -
Juvenile competitive triathlete after cardiotoxic anthracycline therapy for Acute Myeloid Leukemia
por: von Korn, Pia, et al.
Publicado: (2016)